Insider Trading: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

8.30USD
17 Oct 2014
Price Change (% chg)

$-0.08 (-0.95%)
Prev Close
$8.38
Open
$8.58
Day's High
$8.64
Day's Low
$7.70
Volume
9,020,192
Avg. Vol
433,987
52-wk High
$18.19
52-wk Low
$7.70

Search Stocks
Morris Charles Q Options Exercised: 0
Trade Date: Monday, 25 Nov 2013 Price: 13.75
Title: Officer Shares Held: 37,500
Type Traded: Direct Net Change in Shares This Filing: -12,500

Institutional Holders

% Shares Owned: 89.54%
# of Holders: 190
Total Shares Held: 76,921,820
3 Mo. Net Change: 288,515
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 9
# Reduced Positions: 5
# Net Buyers: 4

Officers & Directors

Name Age Since Current Position

Stephen McCluski

62 2009 Independent Chairman of the Board

Daniel Junius

61 2013 President, Chief Executive Officer, Director

David Johnston

58 2013 Chief Financial Officer, Executive Vice President, Principal Financial Officer, Principal Accounting Officer

Ellie Harrison

2014 Chief Human Resource Officer, Vice President

John Lambert

62 2008 Executive Vice President - Research and Development, Chief Scientific Officer

Sandra Poole

2014 Senior Vice President - Technical Operations.

Craig Barrows

2010 Vice President, General Counsel, Secretary

Eric Guempel

2014 Vice President - Product Strategy and Program Management

James O'Leary

49 2008 Vice President, Chief Medical Officer

Theresa Wingrove

55 2011 Vice President - Regulatory Affairs

Peter Williams

59 2009 Vice President - Business Development

Mark Goldberg

53 2011 Independent Director

Dean Mitchell

57 2012 Independent Director

Nicole Onetto

60 2005 Independent Director

Kristine Peterson

54 2012 Independent Director

Howard Pien

56 2009 Independent Director

Joseph Villafranca

69 2004 Independent Director

Richard Wallace

63 2007 Independent Director
Search Stocks